In Prevention of heart attack and stroke Taispin 250mg/75mg Tablet is a combination of two antiplatelet medicines or blood thinners. It prevents blood from clotting inside the veins and arteries. This helps the blood flow freely around your body thereby preventing a heart attack or stroke (or deep vein thrombosis or pulmonary embolism). Both these medicines together prevent the formation of blood clots and also prevent the existing ones from growing blogger in size. Take it regularly and make appropriate lifestyle changes (such as eating healthy and staying active) to maximize the effectiveness of this medicine. Keep taking it even if you feel well.
It is unsafe to consume alcohol with Taispin 250mg/75mg Tablet.
Information regarding the use of Taispin 250mg/75mg Tablet during pregnancy is not available. Please consult your doctor.
Information regarding the use of Taispin 250mg/75mg Tablet during breastfeeding is not available. Please consult your doctor.
Taispin 250mg/75mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Taispin 250mg/75mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Taispin 250mg/75mg Tablet may be needed. Please consult your doctor. Use of Taispin 250mg/75mg Tablet is not recommended in patients with severe kidney disease.
Taispin 250mg/75mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Taispin 250mg/75mg Tablet may be needed. Please consult your doctor. Use of Taispin 250mg/75mg Tablet is not recommended in patients with severe liver disease.
If you miss a dose of Taispin 250mg/75mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More